Pages that link to "Q37887036"

The following pages link to The pharmacology of adrenomedullin 2/intermedin (Q37887036):

Displaying 41 items.

• New insights into pancreatic cancer-induced paraneoplastic diabetes (Q27687766) (← links)
• Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors (Q28278110) (← links)
• Endosomal proteolysis regulates calcitonin gene-related peptide responses in mesenteric arteries (Q28577195) (← links)
• The expanding repertoire of receptor activity modifying protein (RAMP) function (Q28601134) (← links)
• The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors (Q30486707) (← links)
• Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy (Q31118833) (← links)
• First survey and functional annotation of prohormone and convertase genes in the pig. (Q34478471) (← links)
• Localization of receptors for calcitonin-gene-related peptide to intraganglionic laminar endings of the mouse esophagus: peripheral interaction between vagal and spinal afferents? (Q35033864) (← links)
• The prognostic value of intermedin in patients with breast cancer (Q35074448) (← links)
• Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor (Q35856565) (← links)
• Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract (Q35973537) (← links)
• Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes. (Q36153252) (← links)
• Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS. (Q36884693) (← links)
• Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents (Q36958850) (← links)
• Intermedin Restores Hyperhomocysteinemia-induced Macrophage Polarization and Improves Insulin Resistance in Mice. (Q37066058) (← links)
• Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice (Q37208751) (← links)
• Current and future G protein-coupled receptor signaling targets for heart failure therapy (Q37232104) (← links)
• Roles of CLR/RAMP receptor signaling in reproduction and development (Q37262321) (← links)
• Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology. (Q37671310) (← links)
• Adrenomedullin - new perspectives of a potent peptide hormone (Q38763013) (← links)
• Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases (Q39240550) (← links)
• Receptor activity modifying proteins (RAMPs) interact with the VPAC2 receptor and CRF1 receptors and modulate their function (Q39970574) (← links)
• Klotho connects intermedin1-53 to suppression of vascular calcification in chronic kidney disease (Q41515873) (← links)
• Intermedin improves cardiac function and sympathetic neural remodeling in a rat model of post myocardial infarction heart failure (Q42347165) (← links)
• Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice (Q42502891) (← links)
• Adrenomedullin 2 Enhances Beiging in White Adipose Tissue Directly in an Adipocyte-autonomous Manner and Indirectly through Activation of M2 Macrophages. (Q42733291) (← links)
• Current Evidence for a Role of Neuropeptides in the Regulation of Autophagy. (Q42922923) (← links)
• Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives (Q43238779) (← links)
• Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25. (Q46277281) (← links)
• Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate/protein kinase A pathway (Q46493701) (← links)
• Intermedin1-53 Protects Cardiac Fibroblasts by Inhibiting NLRP3 Inflammasome Activation During Sepsis (Q47344257) (← links)
• Cardiac sympathetic afferent reflex response to intermedin microinjection into paraventricular nucleus is mediated by nitric oxide and γ-amino butyric acid in hypertensive rats (Q47865079) (← links)
• Intermedin/adrenomedullin 2 polypeptide promotes adipose tissue browning and reduces high-fat diet-induced obesity and insulin resistance in mice (Q48044554) (← links)
• Cerebellar Adrenomedullinergic System. Role in Cardiovascular Regulation (Q48520174) (← links)
• Metabolic disorders as paraneoplastic syndromes (Q49581415) (← links)
• Central Role of Protein Kinase A in Promoting Trigeminal Nociception in an In Vivo Model of Temporomandibular Disorders (Q50874272) (← links)
• Intermedin in Paraventricular Nucleus Attenuates Sympathoexcitation and Decreases TLR4-Mediated Sympathetic Activation via Adrenomedullin Receptors in Rats with Obesity-Related Hypertension (Q57060488) (← links)
• Inhibition of endoplasmic reticulum stress by intermedin1-53 attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE KO Mice (Q89251164) (← links)
• The Impact of Adrenomedullin Thr22 on Selectivity within the Calcitonin Receptor-like Receptor/Receptor Activity-Modifying Protein System (Q89444533) (← links)
• Sex differences in the expression of calcitonin gene-related peptide receptor components in the spinal trigeminal nucleus (Q92927531) (← links)
• Intermedin in Paraventricular Nucleus Attenuates Ang II-Induced Sympathoexcitation through the Inhibition of NADPH Oxidase-Dependent ROS Generation in Obese Rats with Hypertension (Q92988040) (← links)